Use of Titration as a Therapeutic Individualization Strategy: An Analysis of Food and Drug Administration-Approved Drugs
Selecting a dose regimen that is both safe and effective for patients is one of the most critical elements of a successful drug development program. Titrating the dose regimen of a drug based on patient response may help to identify safe and effective dosages at the individual patient level. Therefo...
Saved in:
Main Authors: | Robert N. Schuck (Author), Michael Pacanowski (Author), Sarah Kim (Author), Rajanikanth Madabushi (Author), Issam Zineh (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2019-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pediatric dosing for locally acting drugs in submissions to the U.S. Food and Drug Administration between 2002 and 2020
by: Gelareh A. Abulwerdi, et al.
Published: (2023) -
Clinical pharmacology information in regulatory submissions and labeling: A comparative analysis of orphan and non‐orphan drugs approved by the FDA
by: Julie Hsieh, et al.
Published: (2022) -
US Food and Drug Administration embraces using innovation to identify optimized dosages for patients with cancer
by: Stacy S. Shord, et al.
Published: (2023) -
Quantitative systems pharmacology: Landscape analysis of regulatory submissions to the US Food and Drug Administration
by: Jane P. F. Bai, et al.
Published: (2021) -
Exploring the Food and Drug Administration's review and approval of Entresto (sacubitril/valsartan)
by: Ashley L. Eadie, et al.
Published: (2021)